Relay Therapeutics develops small molecule drugs for patients with cancer and genetic disease. It last closed at $16.12 on Nov 20, up 1.32% on the day. The next earnings report for RLAY is expected around Thu, Feb 25, 2027, after the close. For the quarter ended Sep 2026, RLAY reported EPS of -$0.37 on revenue of $0. Over its last 8 reports the stock moved an average of 6.5% the session after earnings. Over the last 12 months RLAY insiders bought $0 of stock on the open market and sold $130.7M, according to SEC Form 4 filings.
AI Auto Pilots
Is RLAY in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold RLAY.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on RLAYStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
RLAY · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend
The stock is 12% below its 20 day and 12% below its 50 day average. It is 2% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 39). The nearest support is the Pivot at $15.87, and the nearest resistance the Pivot R1 at $16.57.
Short trendBearish
Long trendBullish
MomentumWeak
StretchNormal
VolatilityNormal, 6.9%/day
Key levels
$21.2752 week high+31.9%
$18.75100 day average+16.3%
$18.1350 day average+12.5%
$18.0720 day average+12.1%
$17.47Swing high (Jun 2)+8.4%
$16.57Pivot R1+2.8%
$16.12Last close
$15.87Pivot−1.6%
$15.74200 day average−2.4%
$15.42Pivot S1−4.3%
$13.30Swing low (Jun 1)−17.5%
$6.2852 week low−61.0%
Indicators
RSI (14)
39.40
Weak, oversold below 30
Neutral
MACD
-0.47
Below its signal line
Bearish
Stochastic
7.6
Near the bottom of its range
Oversold
ADX (14)
17.1
No clear trend
Williams %R
-83.6
Oversold below −80, overbought above −20
Oversold
CCI (20)
-149.0
Oversold below −100, overbought above 100
Oversold
Rate of change
−13.3%
Change over 10 sessions
Bearish
ATR (14)
$1.11
Typical daily range, 6.9% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Above
Moving sideways
Short trendNeutral
Long trendBullish
MomentumFading
StretchNormal
VolatilityNormal, 13.9%/day
Key levels
$21.2752 week high+31.9%
$18.75100 day average+16.3%
$18.1350 day average+12.5%
$18.0720 day average+12.1%
$17.47Swing high (Jun 2)+8.4%
$16.57Pivot R1+2.8%
$16.12Last close
$15.87Pivot−1.6%
$15.74200 day average−2.4%
$15.42Pivot S1−4.3%
$13.30Swing low (Jun 1)−17.5%
$6.2852 week low−61.0%
Indicators
RSI (14)
46.38
Middle of its range
Neutral
MACD
0.78
Below its signal line
Bearish
Stochastic
33.9
Middle of its range
Neutral
ADX (14)
44.2
Strong uptrend
Williams %R
-84.4
Oversold below −80, overbought above −20
Oversold
CCI (20)
-210.3
Oversold below −100, overbought above 100
Oversold
Rate of change
−14.6%
Change over 10 sessions
Bearish
ATR (14)
$2.25
Typical daily range, 13.9% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Above
What happened before, for RLAY
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how RLAY did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow RLAY usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for RLAYHow many large options trades hit RLAY, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in RLAY in the last 90 days.
From SEC Form 4 filings by RLAY's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether RLAY is in one of them and how their past RLAY trades turned out.
From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data
About Relay Therapeutics
Relay Therapeutics is a biotechnology company based in Cambridge, Massachusetts, that develops small molecule drugs for patients with cancer and genetic disease. Its work centers on its Dynamo platform, which uses computational and experimental methods to study how proteins move and to design drugs for protein targets that conventional approaches have struggled to address. Its lead candidate, zovegalisib, is in clinical trials for breast cancer and for vascular anomalies. The company is still testing its therapies, so it does not yet sell medicines to patients.